Omega Therapeutics (OMGA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

OMGA Omega Therapeutics

Watchlist

1.620
+0.090+5.88%

Trading Aug 8 11:46 ET

89.35MMarket Cap-1140P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Omega Therapeutics Price Target Maintained With a $12.00/Share by Wedbush
Dow JonesAug 7 10:50 ET · Ratings
Uber To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Wednesday
BenzingaAug 7 08:26 ET
Express News | Chardan Capital Maintains Buy on Omega Therapeutics, Lowers Price Target to $6
BenzingaAug 7 06:49 ET
Express News | Omega Therapeutics Inc : Chardan Capital Markets Cuts Target Price to $6 From $7
ReutersAug 7 00:07 ET
Omega Therapeutics 2Q Loss/Shr 30c >OMGA
Dow JonesAug 6 07:09 ET
Omega Therapeutics 2Q Rev $2.13M >OMGA
Dow JonesAug 6 07:09 ET

Comments

Jaguar8

May 8 06:01

$Omega Therapeutics (OMGA.US)$
NEWS
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers

David 889

Jan 10 13:03

$Omega Therapeutics (OMGA.US)$ let’s go!

Moomoo Recap US

Jan 5 15:42

Columns Wall Street Today | US Stocks End Weekly Winning Streak

RECAP
Investors Rethink Rate Cut Bets
US equities ended Friday slightly higher, but gains weren't enough to keep major indices in the green in the first trading week of the year. The stock market ended their nine-week winning streak as investors rethink bets of aggressive interest rate cuts this year amid signs of continued strength in the labor market.
The $S&P 500 Index (.SPX.US)$ rose 0.2% to close at 4,697.24 Friday, while the $Nasdaq Composite Index (.IXIC.US)$ rose less...

Fed minutes released: Rate cuts likely, but path highly uncertain

Movers and Shakers

Jan 5 12:02

Columns Omega Therapeutics Shares Sink 18%, Giving Back Some of Meteoric Gains

$Omega Therapeutics (OMGA.US)$ tumbled 18%, giving back some of its meteoric gains on Thursday that were driven by optimism over the clinical-stage biotechnology company's research collaboration pact with Novo Nordisk.
Omega shares almost doubled Thursday after the company said its flagship’s Pioneering Medicines initiative, and Novo Nordisk will jointly advance an obesity management program through preclinical development and...